• Mayo Clinic Laboratories and Amprion announce collaboration to advance neurodegenerative disease diagnostics

    By

    Mayo Clinic Staff

ROCHESTER, Minn. and SAN DIEGO — Mayo Clinic Laboratories and Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced a collaboration to expand access to Amprion's SAAmplify–αSYN (CSF) test across the United States. The test (test ID ASYNC) is available today for clients of Mayo Clinic Laboratories through the collaboration that combines the expertise of both organizations to enhance patient care and improve diagnostic accuracy for neurodegenerative diseases.

Learn more here.

Related Articles

Cancer
What is cancer immunotherapy?
Featured News
A clearer path through a difficult diagnosis
Children's Center
Honoring a young girl’s love of nature on her final day